17 March 2022

Biologics COVID-19 Reactive Arthritis

A silver lining to sulfasalazine’s covid fear

10 March 2022

Comment DMARDS

One-off fixes may get you through the tax crackdowns

3 March 2022

Anti JAKS Biologics COVID-19 Fibromyalgia

Antipyretics ‘reduce covid immunity, help fight TB’

3 March 2022

Biologics COVID-19

Rheumatology patients share their experiences of the covid pandemic

24 February 2022

Ankylosing Spondylitis Biologics Polymyalgia Rheumatica Rheumatoid Arthritis Spondyloarthritis

Why men won’t take allopurinol

24 February 2022

Biologics

Regulatory review – November 2021 PBAC recommendations

17 February 2022

Biologics osteomyelitis Spondyloarthritis

Rates and predictors of MTX side effects

17 February 2022

Biologics Pain Rheumatoid Arthritis

In knee OA, opioid benefits aren’t worth the cost

17 February 2022

Biologics PBS

Naloxone trial ‘saves three Australians a day’

17 February 2022

Biologics Pain

Long-term paracetamol may boost CV risk

3 February 2022

Biologics Comment Complementary Pain Research

The grass is always greener on the alternative side

3 February 2022

DMARDS Technology

Things to know before you go crypto

27 January 2022

NSAIDS The Back Page

The age of non-reason

27 January 2022

Biologics Polymyalgia Rheumatica

Stamp of reassurance for allopurinol in gout + CKD

21 December 2021

NSAIDS

Deck the memes with boughs of holly, Fa la la la la la la la la

16 December 2021

DMARDS

To name or not to name a referral …